AYTU BioPharma (AYTU)

• Market cap: $27M
• 1 day: -1.56%
• 5 days: 0.4%
• 1 month: -4.55%
• 3 months: -3.82%
• 6 months: 16.13%
• Year to date: -9.03%
• 1 year: 131.19%
• 5 years: -98.15%
• 10 years: -99.99%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline, including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates one business segment consisting of various prescription pharmaceutical products sold through third parties.

Employees: 83